Eisai has retreated from the optimistic view of sales growth for Alzheimer's disease drug Leqembi it held earlier this year as uptake remains sluggish. Discover how AI is transforming the pharma ...
MANILA, Philippines — The investments of conglomerate San Miguel Corp. (SMC) for the environment are bearing fruits, making its chairman and CEO Ramon Ang proud of the group’s recent ...
Efanesoctocog alfa is being developed as a successor to Eloctate (efmoroctocog alfa), Sanofi and Sobi's current factor VIII drug that is dosed every four days but has seen its sales decline in an ...